# Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers

> **NCT02286544** · PHASE1 · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 36 (actual)

## Conditions studied

- Myocardial Infarction
- Inflammation
- Acute Coronary Syndrome (ACS)
- Reperfusion Injury

## Interventions

- **BIOLOGICAL:** Salmonella typhi vaccine (Typhim Vi®)
- **DRUG:** Oxygen (Oxymask®)
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT02286544
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02286544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02286544, "Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02286544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*